Results from a retrospective study presented at the 2018 BMT Tandem Meetings dispute age as a limiting factor to transplant eligibility, showing no differences in 4-year outcomes for patients older or younger than age 65.
New research published in The Journal of Physiology sheds light on the effects of high blood pressure by considering the way the body responds to a lack of oxygen.
A new study published today found that a newly discovered gene helps grow blood vessels when it senses inadequate blood flow to tissues.
New tests which can indicate autism in children have been developed by researchers at the University of Warwick. The academic team who conducted the international research believe that their new blood and urine tests which search for damage to proteins are the first of their kind.
Rice University bioengineer Gang Bao and his colleagues use gene editing to correct the mutation responsible for sickle cell disease in up to 40 percent of patients' cells used for lab testing.
Using a computational model of the human immune system, scientists have shown that efforts to combat sepsis might be more effective if they targeted multiple steps in the molecular processes that drive the illness. This finding is presented in PLOS Computational Biology.
Bone cells do not just form new bone, they also influence the blood sugar level. Leuven scientists have now discovered a new mechanism that controls this link. The metabolism of bone cells determines how much sugar they use; if the bone cells consume more sugar than normal, this can lower the glucose level in the blood. This research may contribute to future therapies for conditions such as osteoporosis and diabetes.
Even though diseases of the brain vasculature are some of the most common causes of death in the West, knowledge of these blood vessels is limited. Now researchers from Uppsala University and Karolinska Institutet in Sweden present in the journal Nature a detailed molecular atlas of the cells that form the brain's blood vessels and the life-essential blood-brain barrier. The atlas provides new clues to which cell types are involved in different diseases.
Results of the phase II OPTIMA clinical trial indicate that patients with head and neck cancers associated with the human papillomavirus (HPV), including those with advanced nodal disease, can receive substantially lower radiation doses safely and effectively if they respond to induction chemotherapy initially.
Results of a new phase II clinical trial indicate that cabozantinib offers an active therapy option for patients with differentiated thyroid cancer (DTC) that has progressed following surgery and treatment with radioactive iodine (RAI). Thirty-four of 35 patients in the trial experienced a reduction in tumor size following treatment with the targeted kinase inhibitor, and more than half experienced reductions in excess of 30 percent.